Risk Assessment of Acute Myocardial Infarction and Stroke Associated with Long-Acting Muscarinic Antagonists, Alone or in Combination, versus Long-Acting beta2-Agonists

Author
C. Rebordosa
E. Plana
A. Rubino
J. Aguado
D. Martinez
A. Lei
S. Daoud
N. Saigi-Morgui
S. Perez-Gutthann
E. Rivero-Ferrer
Keywords
Administration, Inhalation
Adrenal Cortex Hormones/therapeutic use
Adrenergic beta-2 Receptor Agonists/adverse effects
Adult
Bronchodilator Agents/adverse effects
Cohort Studies
Drug Therapy, Combination
Formoterol Fumarate/adverse effects
Humans
Muscarinic Antagonists/adverse effects
*Myocardial Infarction/chemically induced/diagnosis/epidemiology
*Pulmonary Disease, Chronic Obstructive/diagnosis/drug therapy/epidemiology
Risk Assessment
*Stroke/diagnosis/epidemiology
Tiotropium Bromide/adverse effects
Lama
United Kingdom
aclidinium
Acute myocardial infarction
Stroke
Year of Publication
2022
Journal
Int J Chron Obstruct Pulmon Dis
Volume
17
Number of Pages
1715-1733
ISBN Number
1176-9106 (Print)1176-9106
Accession Number
35941901
DOI
10.2147/copd.s363997